Spire Healthcare Group's (SPI) "Buy" Rating Reaffirmed at Berenberg Bank

Key Points

• Berenberg Bank reiterated a "buy" rating for Spire Healthcare Group (LON:SPI), setting a target price of GBX 280 ($3.71), suggesting a potential upside of 25.98% from the current price.
• Shares of Spire Healthcare traded down 1.2% to GBX 222.25 ($2.95), with a market capitalization of £892.50 million.
• The company offers a variety of medical services, including cancer treatments, cosmetic surgery, and screenings through its network of private hospitals and clinics.

Spire Healthcare Group (LON:SPI - Get Free Report)'s stock had its "buy" rating reiterated by stock analysts at Berenberg Bank in a research report issued on Thursday, Marketbeat reports. They currently have a GBX 280 ($3.72) target price on the stock. Berenberg Bank's price objective indicates a potential upside of 32.70% from the company's previous close.

Spire Healthcare Group Trading Down 3.2%

Shares of Spire Healthcare Group stock traded down GBX 7 ($0.09) on Thursday, reaching GBX 211 ($2.80). 867,901 shares of the company's stock were exchanged, compared to its average volume of 1,358,704. The company has a market capitalization of £847.31 million, a P/E ratio of 30.03, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. Spire Healthcare Group has a 52 week low of GBX 168.20 ($2.23) and a 52 week high of GBX 260.50 ($3.46). The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The firm's 50-day moving average is GBX 215.36 and its two-hundred day moving average is GBX 206.63.

Spire Healthcare Group (LON:SPI - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported GBX 4.10 ($0.05) earnings per share (EPS) for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. Sell-side analysts predict that Spire Healthcare Group will post 15.6634747 EPS for the current fiscal year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.